Market Size in 2021 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 380 Million | USD 700 Million | 8.05% | 2021 |
FrequentlyAsked Questions
The major factors influencing the growth of the superdisintegrants market include increase in the adoption of orally disintegrating tablets (ODTs), rise in the cases of chronic and neurological diseases among people, surge in the geriatric population, increase in healthcare expenditure, and prevalence of remarkable R&D activities in healthcare.
According to the report, the global superdisintegrants market was USD 380 Million in 2021 and is projected to grow around USD 700 Million by 2030, with a compounded annual growth rate (CAGR) of roughly 8.05% from 2022 to 2030.
The global superdisintegrants industry is driven by the North American region. The major reason for the growth of the market in this region is increase in awareness about technological advancements in various drug delivery procedures, surge in demand for generic drugs, surge in the geriatric population, rise in the cases of Alzheimer’s disease, and presence of eminent pharmaceutical players in this region.
The major players of the global superdisintegrants market include DFEPharma, JRSPHARMA, Merck KGaA, Avantor, Inc., Corel PharmaChem, DuPont, Asahi Kasei Corporation, Dow, BASF SE, Ashland, NIPPO SODA CO., LTD., and RoquetteFreres, among other global players.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed